As of 2025-05-03, the EV/EBITDA ratio of Karuna Therapeutics Inc (KRTX) is -25.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KRTX's latest enterprise value is 12,397.19 mil USD. KRTX's TTM EBITDA according to its financial statements is -492.49 mil USD. Dividing these 2 quantities gives us the above KRTX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 12.1x | 10.8x |
| Forward P/E multiples | 15.8x - 32.7x | 19.9x |
| Fair Price | (198.84) - (151.59) | (193.29) |
| Upside | -160.3% - -146.0% | -158.6% |
| Date | EV/EBITDA |